These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2117768)

  • 1. Paired analysis of thromboxane and prostacyclin metabolites in urine from healthy mothers and their children.
    Benthin G; Cederqvist T; Ciabattoni G; Kjellmer I; Wennmalm A
    Prostaglandins; 1990 Jul; 40(1):81-8. PubMed ID: 2117768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring of the thromboxane A2/prostacyclin ratio in the urine of patients with retinal vascular occlusion through the low-dose-aspirin therapy using the gas chromatography/selected ion monitoring method.
    Mizugaki M; Hishinuma T; Matsumura E; Murai Y; Yamazaki T; Yamanobe S; Tamai M
    Prostaglandins Other Lipid Mediat; 1999 Nov; 58(5-6):253-62. PubMed ID: 10593167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2,3-Dinor metabolites of thromboxane A2 and prostacyclin in urine from healthy human subjects: diurnal variation and relation to 24h excretion.
    Wennmalm A; Benthin G; Granström EF; Persson L; Winell S
    Clin Sci (Lond); 1992 Oct; 83(4):461-5. PubMed ID: 1330409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostacyclin versus thromboxane metabolite excretion: changes in pregnancy and labor.
    Noort WA; Keirse MJ
    Eur J Obstet Gynecol Reprod Biol; 1990 Apr; 35(1):15-21. PubMed ID: 2107105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary excretion of thromboxane and prostacyclin metabolites during chronic low-dose aspirin: evidence for an extrarenal origin of urinary thromboxane B2 and 6-keto-prostaglandin F1 alpha in healthy subjects.
    Chiabrando C; Rivoltella L; Martelli L; Valzacchi S; Fanelli R
    Biochim Biophys Acta; 1992 Feb; 1133(3):247-54. PubMed ID: 1737057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man.
    FitzGerald GA; Oates JA; Hawiger J; Maas RL; Roberts LJ; Lawson JA; Brash AR
    J Clin Invest; 1983 Mar; 71(3):676-88. PubMed ID: 6338043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Excretion of thromboxane metabolites in healthy women after cessation of smoking.
    Rångemark C; Ciabattoni G; Wennmalm A
    Arterioscler Thromb; 1993 Jun; 13(6):777-82. PubMed ID: 8499397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thromboxane and prostacyclin formation in patients with deep vein thrombosis.
    Vesterqvist O; Gréen K; Johnsson H
    Thromb Res; 1987 Feb; 45(4):393-402. PubMed ID: 3554598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Excretion of prostacyclin and thromboxane A2 metabolites during leg exercise in humans.
    Wennmalm A; Fitzgerald GA
    Am J Physiol; 1988 Jul; 255(1 Pt 2):H15-8. PubMed ID: 3293469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary thromboxane, prostacyclin, cortisol, and 8-hydroxy-2'-deoxyguanosine in nonsmokers exposed and not exposed to environmental tobacco smoke.
    Smith CJ; Fischer TH; Heavner DL; Rumple MA; Bowman DL; Brown BG; Morton MJ; Doolittle DJ
    Toxicol Sci; 2001 Feb; 59(2):316-23. PubMed ID: 11158725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enzyme immunoassay measurement of the urinary metabolites of thromboxane A2 and prostacyclin.
    Lellouche F; Fradin A; Fitzgerald G; Maclouf J
    Prostaglandins; 1990 Sep; 40(3):297-310. PubMed ID: 2247619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo biosynthesis of thromboxane and prostacyclin during exposure to physiological levels of epinephrine.
    Vesterqvist O; Rasmanis G; Gréen K; Edhag O; Henriksson P
    Prostaglandins Leukot Essent Fatty Acids; 1989 Mar; 35(3):165-7. PubMed ID: 2652147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary excretion of degradation products of prostacyclin and thromboxane is increased in patients with gestational choriocarcinoma.
    Aitokallio-Tallberg AM; Jung JK; Kim SJ; Viinikka LU; Ylikorkala RO
    Cancer Res; 1991 Aug; 51(16):4146-8. PubMed ID: 1868436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal prostacyclin and thromboxane in normotensive and preeclamptic pregnant women and their infants.
    Ylikorkala O; Pekonen F; Viinikka L
    J Clin Endocrinol Metab; 1986 Dec; 63(6):1307-12. PubMed ID: 3536979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary excretion of prostacyclin and thromboxane metabolites in threatened preterm labor: effect of indomethacin and nylidrin.
    Kurki T; Viinikka L; Ylikorkala O
    Am J Obstet Gynecol; 1992 Jan; 166(1 Pt 1):150-4. PubMed ID: 1733190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary excretion of prostacyclin in a rat model of uteroplacental vasculature occlusion: implications for fetal growth retardation.
    Hophy M; Harel S; Yavin E
    Reprod Fertil Dev; 1996; 8(5):895-901. PubMed ID: 8876049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of intracardiac repair on biosynthesis of thromboxane A2 and prostacyclin in children with a left to right shunt.
    Adatia I; Barrow SE; Stratton PD; Ritter JM; Haworth SG
    Br Heart J; 1994 Nov; 72(5):452-6. PubMed ID: 7818962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Desogestrel- and levonorgestrel-containing oral contraceptives have different effects on urinary excretion of prostacyclin metabolites and serum high density lipoproteins.
    Ylikorkala O; Kuusi T; Tikkanen MJ; Viinikka L
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1238-42. PubMed ID: 2960690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of very low dose and enteric-coated acetylsalicylic acid on prostacyclin and thromboxane formation and on bleeding time in healthy subjects.
    Bode-Böger SM; Böger RH; Schubert M; Frölich JC
    Eur J Clin Pharmacol; 1998; 54(9-10):707-14. PubMed ID: 9923572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-invasive assessment of the cardiovascular eicosanoids, thromboxane A2 and prostacyclin, in randomly sampled males, with special reference to the influence of inheritance and environmental factors.
    Wennmalm A; Benthin G; Caidahl K; Granström EF; Lanne B; Persson L; Petersson AS; Winell S
    Clin Sci (Lond); 1990 Dec; 79(6):639-45. PubMed ID: 2176952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.